Organoclick AB
OrganoClick AB (publ), a green chemical company, develops and markets biobased and biodegradable chemical products and material technologies for the treatment of nonwoven, technical textile, and wood in Sweden, Other Nordics, the Rest of Europe, Asia, North America, and Oceania. The company offers OrganoTex, a biodegradable and durable water repellent (DWR) technology for textile and shoe impregn… Read more
Organoclick AB (ORGC) - Net Assets
Latest net assets as of December 2025: Skr20.41 Million SEK
Based on the latest financial reports, Organoclick AB (ORGC) has net assets worth Skr20.41 Million SEK as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr135.22 Million) and total liabilities (Skr114.81 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Skr20.41 Million |
| % of Total Assets | 15.09% |
| Annual Growth Rate | 3.36% |
| 5-Year Change | -81.06% |
| 10-Year Change | -50.79% |
| Growth Volatility | 221.71 |
Organoclick AB - Net Assets Trend (2012–2025)
This chart illustrates how Organoclick AB's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Organoclick AB (2012–2025)
The table below shows the annual net assets of Organoclick AB from 2012 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | Skr20.41 Million | -46.06% |
| 2024-12-31 | Skr37.83 Million | -29.16% |
| 2023-12-31 | Skr53.41 Million | -20.95% |
| 2022-12-31 | Skr67.56 Million | -37.29% |
| 2021-12-31 | Skr107.73 Million | +29.88% |
| 2020-12-31 | Skr82.94 Million | -19.06% |
| 2019-12-31 | Skr102.47 Million | +194.47% |
| 2018-12-31 | Skr34.80 Million | -35.90% |
| 2017-12-31 | Skr54.29 Million | +30.88% |
| 2016-12-31 | Skr41.48 Million | -30.27% |
| 2015-12-31 | Skr59.48 Million | +797.42% |
| 2014-12-31 | Skr6.63 Million | -69.37% |
| 2013-12-31 | Skr21.64 Million | +62.83% |
| 2012-12-31 | Skr13.29 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Organoclick AB's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 30558703600.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Skr1.10 Million | 7.25% |
| Other Components | Skr327.65 Million | 2158.72% |
| Total Equity | Skr15.18 Million | 100.00% |
Organoclick AB Competitors by Market Cap
The table below lists competitors of Organoclick AB ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
JHS Svendgaard Laboratories Limited
NSE:JHS
|
$4.39 Million |
|
PT Ecocare Indo Pasifik Tbk
JK:HYGN
|
$4.39 Million |
|
Energy Focu
NASDAQ:EFOI
|
$4.39 Million |
|
Classover Holdings, Inc. Class B Common Stock
NASDAQ:KIDZ
|
$4.40 Million |
|
Han Kook Steel
KO:025890
|
$4.39 Million |
|
Grid Metals Corp
OTCQB:MSMGF
|
$4.39 Million |
|
Decade Resources Ltd
PINK:DECXF
|
$4.39 Million |
|
WASGAU Produktions & Handels AG
F:MSH
|
$4.39 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Organoclick AB's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 28,976,000 to 15,178,000, a change of -13,798,000 (-47.6%).
- Net loss of 36,372,000 reduced equity.
- Share repurchases of 20,182,000 reduced equity.
- New share issuances of 20,182,000 increased equity.
- Other comprehensive income decreased equity by 142,999.
- Other factors increased equity by 22,716,999.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Skr-36.37 Million | -239.64% |
| Share Repurchases | Skr20.18 Million | -132.97% |
| Share Issuances | Skr20.18 Million | +132.97% |
| Other Comprehensive Income | Skr-143.00K | -0.94% |
| Other Changes | Skr22.72 Million | +149.67% |
| Total Change | Skr- | -47.62% |
Book Value vs Market Value Analysis
This analysis compares Organoclick AB's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 9.40x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 4.88x to 9.40x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-12-31 | Skr0.29 | Skr1.40 | x |
| 2013-12-31 | Skr0.11 | Skr1.40 | x |
| 2014-12-31 | Skr-0.18 | Skr1.40 | x |
| 2015-12-31 | Skr0.65 | Skr1.40 | x |
| 2016-12-31 | Skr0.32 | Skr1.40 | x |
| 2017-12-31 | Skr0.46 | Skr1.40 | x |
| 2018-12-31 | Skr0.16 | Skr1.40 | x |
| 2019-12-31 | Skr0.97 | Skr1.40 | x |
| 2020-12-31 | Skr0.58 | Skr1.40 | x |
| 2021-12-31 | Skr1.05 | Skr1.40 | x |
| 2022-12-31 | Skr0.60 | Skr1.40 | x |
| 2023-12-31 | Skr0.46 | Skr1.40 | x |
| 2024-12-31 | Skr0.30 | Skr1.40 | x |
| 2025-12-31 | Skr0.15 | Skr1.40 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Organoclick AB utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -239.64%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -34.25%
- • Asset Turnover: 0.79x
- • Equity Multiplier: 8.91x
- Recent ROE (-239.64%) is below the historical average (-83.42%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | -54.07% | -741.39% | 0.05x | 1.37x | Skr-9.46 Million |
| 2013 | -177.95% | -133.94% | 0.26x | 5.20x | Skr-10.97 Million |
| 2014 | 0.00% | -74.69% | 0.85x | 0.00x | Skr-14.40 Million |
| 2015 | -47.14% | -65.52% | 0.37x | 1.94x | Skr-24.19 Million |
| 2016 | -137.53% | -77.02% | 0.46x | 3.85x | Skr-32.09 Million |
| 2017 | -85.25% | -36.92% | 0.73x | 3.15x | Skr-30.81 Million |
| 2018 | -167.42% | -25.82% | 0.89x | 7.29x | Skr-21.45 Million |
| 2019 | -23.62% | -21.47% | 0.49x | 2.23x | Skr-26.13 Million |
| 2020 | -36.10% | -20.24% | 0.63x | 2.83x | Skr-24.93 Million |
| 2021 | -30.93% | -28.20% | 0.58x | 1.88x | Skr-41.07 Million |
| 2022 | -70.81% | -36.18% | 0.71x | 2.77x | Skr-47.50 Million |
| 2023 | -35.38% | -10.81% | 0.97x | 3.38x | Skr-20.23 Million |
| 2024 | -62.02% | -14.12% | 1.00x | 4.38x | Skr-20.87 Million |
| 2025 | -239.64% | -34.25% | 0.79x | 8.91x | Skr-37.89 Million |
Industry Comparison
This section compares Organoclick AB's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $191,970,505
- Average return on equity (ROE) among peers: -46.79%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Organoclick AB (ORGC) | Skr20.41 Million | -54.07% | 5.63x | $4.39 Million |
| Svenska Aerogel Holding AB (publ) (AERO) | $52.02 Million | -76.93% | 0.76x | $1.21 Million |
| Arla Plast AB (ARPL) | $389.45 Million | 20.58% | 0.48x | $36.28 Million |
| aXichem AB (AXIC-A) | $53.65 Million | -25.19% | 0.04x | $4.70 Million |
| I-Tech (ITECH) | $116.03 Million | 9.15% | 0.08x | $41.86 Million |
| KB Components AB (publ) (KBC) | $600.79 Million | 16.50% | 2.73x | $110.94 Million |
| Nexam Chemical Holding AB (NEXAM) | $183.31 Million | -4.91% | 0.26x | $16.50 Million |
| Photocat AS (PCAT) | $11.30 Million | -19.11% | 0.63x | $2.25K |
| Polygiene AB (POLYG) | $319.61 Million | 5.27% | 0.10x | $6.01 Million |
| Triboron International AB (publ) (TRIBO-B) | $1.57 Million | -346.46% | 1.18x | $1.87 Million |